The patient, a 69 years old female, came to our institution for treatment because of repeated chest tightness for one week, which was located in the xiphoid process, and could appear during rest and activity. The symptoms improved after several hours without chest pain, palpitation and other discomfort. The patient had a history of erosive gastritis without other chronic history as hypertension, diabetes etc. Deny any smoking or drinking habits. Under the current situation, her hypersensitive troponin I (hs-TnI) level was 14.00pg/mL (normal value 0-17.5pg/mL), myoglobin level was 54.3ug/L (normal value < 70ug/L), Pro-B-type natriuretic peptide (Pro-BNP) level was 269.0pg/mL (normal value ≤ 300pg/mL) (Fig. 1), total cholesterol (TC) level was 5.98mmol/L (normal value 2.9-5.5mmol/L), low-density lipoprotein cholesterol (LDL-C) level was 3.85mmol/L (normal value 2.5-4.14mmol/L). ECG showed sinus rhythm (Fig. 2A). Echocardiography revealed that the size of each atrioventricular cavity was normal, the left ventricular ejection fraction (LVEF) was 73%(Fig. 3A). On the fourth day after admission, coronary angiogram showed that the bifurcation between the middle part of the left anterior descending artery (LAD) and the first diagonal branch (D1) of the LAD had a stenosis of about 80%. During the operation, a 3.0 * 18mm stent was placed in the LAD and D1 was protected with Jailed balloon technique (Fig. 4A-D). The procedure went smoothly without signs of vascular entrapment, stent strut malapposition and tissue prolapse. Tirofiban was continuously pumped after the operation in conjunction with oral antiplatelet drugs: 90 mg of Tigrenol twice a day and 100 mg of Indobufen twice a day.
On the first day after operation, the hs-TnI: 13045.50pg/mL, Pro-BNP: 5255.0pg/mL (Fig. 1), ECG showed sinus rhythm, V1-V5 ST segment elevation, T wave changes (Fig. 2B), emergency coronary angiogram showed stent shadow in the middle of LAD, and blood circulation in the stent was smooth. There is no obvious stenosis in the left circumflex coronary artery (LCX) and the right coronary artery (RCA) (Fig. 4E-F), and the blood flow in all three vessels is TIMI grade 3. LVO reveals that the middle and lower segments of the ventricular septum, the anterior wall of the left ventricle, and the ventricular wall of the apical segment become thinner, and the movement is weakened with decreased perfusion, with LVEF of 51% (Fig. 3B). Subsequent CMR presented that the motion of the middle and lower segments of the ventricular septum and the ventricular wall at the apex was weakened (Fig. 5A-D).
Based on the patient's medical history, symptoms, laboratory examination, imaging and other auxiliary examination results, the diagnosis is considered as 1. Takotsubo syndrome (TTS); 2. Coronary atherosclerotic heart disease. We provide this patient furosemide 60mg/d、β blocker 2.5mg/d as TTS pharmacological therapies. Simultaneously, the patient with coronary atherosclerotic heart disease received a stent and continued to be treated with dual antiplatelet drugs and statins. On the 4th day after surgery, the re-examination ECG revealed that the T wave of lead V2∼V4 was inverted, broad, and deep (Fig. 2C), and that the levels of hs-TnI and Pro-BNP were significantly reduced (Fig. 1). On the seventh postoperative day, LVO revealed that the left ventricular wall motion was greatly improved compared to before, with good myocardial perfusion and LVEF of 65% (Fig. 3C). The patient was discharged after receiving an additional 12.5mg of Sakubatravalsartan twice day. .
2 months later, the patient returned to the institution for a check, she had a hs-cTnI level of 12.30pg/mL, a pro-BNP level of 324.00pg/mL, and no evidence of ST-T segment changes on ECG. LVO demonstrated no obvious motion abnormalities in the myocardial segments of each ventricular wall, and the perfusion was adequate, with LVEF of 59% (Fig. 3D). CMR demonstrated improvement in left ventricular systolic function in comparison with the former (Fig. 5E-H). Changes of echocardiography was shown in Table 2.